How Much Did Intermountain Life Sciences Raise?
Funding & Key Investors

Intermountain Life Sciences has solidified its market position through a significant capital infusion, reaching a cumulative total of $150K. This latest major strategic investment of $150K underscores the firm's critical role in the pharmaceutical supply chain. By securing this financing, the company is well-positioned to expand its operational capacity and meet the rising demand for high-purity manufacturing inputs in the life sciences sector.

The influx of capital serves as a testament to the company's robust business model and its essential contribution to global bioprocessing standards. As the industry shifts toward more stringent regulatory requirements, Intermountain Life Sciences remains a pivotal player in providing the necessary infrastructure for drug development and large-scale production.

What is Intermountain Life Sciences?

Intermountain Life Sciences
ManufacturingPharmaceuticalsChemicals & Related Products

Intermountain Life Sciences operates at the intersection of biotechnology and industrial manufacturing, specializing in the production of high-purity water for pharmaceutical applications, purification buffers, and GMP-compliant process liquids. The company serves as a foundational partner for pharmaceutical manufacturers, ensuring that critical fluid components meet the rigorous quality benchmarks required for clinical and commercial drug production. By maintaining a focus on high-purity standards, the firm mitigates supply chain risks for its clients, positioning itself as an indispensable entity within the bioprocessing ecosystem. Its expertise in GMP process liquids allows it to support complex workflows, from early-stage research to full-scale commercial manufacturing, thereby enhancing the efficiency and reliability of the broader life sciences industry.

How much funding has Intermountain Life Sciences raised?

Intermountain Life Sciences has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Intermountain Life Sciences

PPP

Public-Private Partnership

What's next for Intermountain Life Sciences?

With this recent capital injection, Intermountain Life Sciences is expected to prioritize the scaling of its production facilities and the enhancement of its quality control infrastructure. The strategic deployment of these funds will likely focus on increasing output capacity to address the growing global demand for high-purity pharmaceutical inputs. Furthermore, the company is poised to invest in advanced purification technologies, ensuring that its product portfolio remains at the forefront of industry standards. As the firm enters this next phase of growth, it will likely explore opportunities to deepen its market penetration, leveraging its reputation for precision and reliability to secure long-term partnerships with major pharmaceutical and biotech organizations. This trajectory suggests a focus on operational excellence and sustainable expansion within the highly regulated bioprocessing market.

See full Intermountain Life Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Food & BeverageManufacturing
ManufacturingMedical Devices & Equipment
ManufacturingMedical Devices & EquipmentBusiness ServicesResearch & Development

Frequently Asked Questions Regarding Intermountain Life Sciences Financial Insights

What are the most recent funding rounds that Intermountain Life Sciences has completed, and what were the funding rounds?
Intermountain Life Sciences has recently completed 1 funding rounds: Debt on Apr 10, 2020.
What is the total amount of funding Intermountain Life Sciences has raised to date?
Intermountain Life Sciences has raised a total of $150K in funding to date.
How many funding rounds has Intermountain Life Sciences completed?
Intermountain Life Sciences has completed 1 funding rounds.
How much funding did Intermountain Life Sciences raise in its most recent funding round?
Intermountain Life Sciences raised $150K in its most recent funding round.
Who are the lead investors in Intermountain Life Sciences's latest funding round?
The lead investor in Intermountain Life Sciences's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Intermountain Life Sciences's history?
The largest funding round in Intermountain Life Sciences's history was $150K.
See more information about Intermountain Life Sciences